Powder: -20°C for 3 years | In solvent: -80°C for 1 year
OS-3-106 is a novel arylamide phenylpiperazines, as partial agonists at the D3R in the adenylyl cyclase inhibition assay.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
5 mg | 在庫あり | ¥ 11,000 | |||
10 mg | 在庫あり | ¥ 19,500 | |||
25 mg | 在庫あり | ¥ 41,000 | |||
50 mg | 在庫あり | ¥ 72,000 | |||
100 mg | 在庫あり | ¥ 122,500 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 14,500 |
説明 | OS-3-106 is a novel arylamide phenylpiperazines, as partial agonists at the D3R in the adenylyl cyclase inhibition assay. |
In vitro | The effect of OS-3-106 (10 mg/kg) on the dose-response function of cocaine self-administration.?OS-3-106 decreased cocaine and sucrose reinforcement rates, increased latency to first response for cocaine but not sucrose, and downshifted the cocaine self-administration dose-response function.?Thish compounds blocked a D3R-mediated behavior. |
分子量 | 450.6 |
分子式 | C25H30N4O2S |
CAS No. | 1580000-17-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 4.51 mg/mL (10 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
OS-3-106 1580000-17-4 GPCR/G Protein Neuroscience Dopamine Receptor Inhibitor inhibit HEK 293 cells self-administration arylamide phenylpiperazine OS 3 106 psychostimulant addiction cocaine sucrose OS3106 inhibitor